» Articles » PMID: 27381164

Role of Astrocyte-synapse Interactions in CNS Disorders

Overview
Journal J Physiol
Specialty Physiology
Date 2016 Jul 7
PMID 27381164
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes comprise half of the cells in the brain. Although astrocytes have traditionally been described as playing a supportive role for neurons, they have recently been recognized as active participants in the development and plasticity of dendritic spines and synapses. Astrocytes can eliminate dendritic spines, induce synapse formation, and regulate neurotransmission and plasticity. Dendritic spine and synapse impairments are features of many neurological disorders, including autism spectrum disorder, schizophrenia, and Alzheimer's disease. In this review we will present evidence from multiple neurological disorders demonstrating that changes in astrocyte-synapse interaction contribute to the pathologies. Genomic analysis has connected altered astrocytic gene expression with synaptic deficits in a number of neurological disorders. Alterations in astrocyte-secreted factors have been implicated in the neuronal morphology and synaptic changes seen in neurodevelopmental disorders, while alteration in astrocytic glutamate uptake is a core feature of multiple neurodegenerative disorders. This evidence clearly demonstrates that maintaining astrocyte-synapse interaction is crucial for normal central nervous system functioning. Obtaining a better understanding of the role of astrocytes at synapses in health and disease will provide a new avenue for future therapeutic targeting.

Citing Articles

What autism features in first episode psychosis? Results from a 2-year follow-up study.

Pelizza L, Federico A, Leuci E, Quattrone E, Palmisano D, Pupo S Eur Arch Psychiatry Clin Neurosci. 2025; .

PMID: 40045056 DOI: 10.1007/s00406-025-01986-1.


NaHS modulates astrocytic EAAT2 expression to impact SNI-induced neuropathic pain and depressive-like behaviors.

Qi M, Peng H, Zhang T, Li Y, Gao M, Sun W Sci Rep. 2025; 15(1):2874.

PMID: 39843656 PMC: 11754697. DOI: 10.1038/s41598-025-86885-0.


JZL-184 Alleviate Neurological Impairment through Regulation of Mitochondrial Transfer and Lipid Droplet Accumulation after Cardiac Arrest.

Zhang Q, Zhang C, Lu Y, Zhan H, Li B, Wei H Mol Neurobiol. 2024; .

PMID: 39718743 DOI: 10.1007/s12035-024-04633-3.


Neuropeptide-mediated activation of astrocytes improves stress resilience in mice by modulating cortical neural synapses.

Cui J, Wang X, Yu J, Zhang B, Shi Y, So K Acta Pharmacol Sin. 2024; .

PMID: 39643639 DOI: 10.1038/s41401-024-01420-7.


Dual-phase SilMA hydrogel: a dynamic scaffold for sequential drug release and enhanced spinal cord repair via neural differentiation and immunomodulation.

Zhang R, Zhang M, Chen L, Jiang L, Zou C, Li N Front Bioeng Biotechnol. 2024; 12:1501488.

PMID: 39640066 PMC: 11617199. DOI: 10.3389/fbioe.2024.1501488.


References
1.
Yoshihara Y, De Roo M, Muller D . Dendritic spine formation and stabilization. Curr Opin Neurobiol. 2009; 19(2):146-53. DOI: 10.1016/j.conb.2009.05.013. View

2.
Halpain S, Hipolito A, Saffer L . Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci. 1998; 18(23):9835-44. PMC: 6793298. View

3.
Calfa G, Percy A, Pozzo-Miller L . Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood). 2011; 236(1):3-19. PMC: 3059199. DOI: 10.1258/ebm.2010.010261. View

4.
Hinton V, Brown W, Wisniewski K, Rudelli R . Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet. 1991; 41(3):289-94. DOI: 10.1002/ajmg.1320410306. View

5.
Kucukdereli H, Allen N, Lee A, Feng A, Ozlu M, Conatser L . Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A. 2011; 108(32):E440-9. PMC: 3156217. DOI: 10.1073/pnas.1104977108. View